US Patent Issued to MAB-LEGEND BIOTECH on March 4 for "Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,914, issued on March 4, was assigned to MAB-LEGEND BIOTECH Co. LTD. (Shanghai).

"Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof" was invented by Shaoxiong Wang (Shanghai), Juehua Xu (Shanghai), Yunhua Zhou (Shanghai) and Yongfeng Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided in the present application are an antibody against factor XIa in the activated form of coagulant factor XI, a preparation method therefor and the use thereof. The CDR of the heavy chain variable region of the antigen-binding fragment of the antibody comprises the amino acid sequence shown...